ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,622Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 19

$1.12M Total Retail Price of All Prescriptions

Rank: 2 out of 19

491 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 491 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

7% of this provider’s 491 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 20,667 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $41 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 31.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 2,359 2,284 1 1
SIMVASTATIN 888 813 2 2
FUROSEMIDE 871 852 3 3
TRAZODONE HCL 859 817 4 6
METOPROLOL TARTRATE 616 588 5 10
LEVOTHYROXINE SODIUM 605 582 6 4
LISINOPRIL 604 577 7 5
MIRTAZAPINE 578 551 8 11
AMLODIPINE BESYLATE 540 519 9 8
DONEPEZIL HCL 440 420 10 7
GABAPENTIN 438 377 11 13
METOPROLOL SUCCINATE 416 405 12 14
POTASSIUM CHLORIDE 401 376 13 19
DIVALPROEX SODIUM 397 333 14 18
CITALOPRAM HBR 349 346 15 12
OMEPRAZOLE 338 325 16 9
SERTRALINE HCL 308 299 17 20
QUETIAPINE FUMARATE 305 281 18 22
ESCITALOPRAM OXALATE 300 283 19 48
NAMENDA 275 254 20 15
OLANZAPINE 233 176 21 25
ATENOLOL 205 189 22 21
TRAMADOL HCL 201 194 23 27
DIGOXIN 189 180 24 28
CYMBALTA 180 173 25 36
RISPERIDONE 173 163 26 24
PREDNISONE 171 161 27 23
ATORVASTATIN CALCIUM 168 148 28 16
METFORMIN HCL 160 150 29 17
ENOXAPARIN SODIUM 151 129 30 88
OXYCODONE HCL 148 131 S2 31 72
IPRATROPIUM-ALBUTEROL 136 133 32 51
LEVETIRACETAM 133 103 33 60
VENLAFAXINE HCL 132 132 34 76
GLIMEPIRIDE 132 130 34 57
TAMSULOSIN HCL 131 131 36 29
SEROQUEL 124 117 37 41
CARBIDOPA-LEVODOPA 117 107 38 44
POLYETHYLENE GLYCOL 3350 116 90 39 33
LANTUS 115 108 40 31
CLOZAPINE 114 36 41 62
LIDODERM 113 97 42 40
BUPROPION HCL 110 84 43 102
DILTIAZEM 24HR CD 108 96 44 50
RANITIDINE HCL 108 79 44 42
HYDROCODONE-ACETAMINOPHEN 107 101 S3 46 30
VENLAFAXINE HCL ER 105 92 47 38
LEXAPRO 104 103 48 109
BACLOFEN 104 62 48 65
CEFPODOXIME PROXETIL 100 98 10 50 110
FLUOXETINE HCL 96 70 51 64
LABETALOL HCL 96 67 51 113
FINASTERIDE 90 90 53 54
CEPHALEXIN 89 81 54 89
ALLOPURINOL 89 79 54 46
ISOSORBIDE MONONITRATE ER 87 87 56 43
ABILIFY 76 56 57 39
DIOVAN 74 74 58 74
HYDROCHLOROTHIAZIDE 72 72 59 26
LACTULOSE 72 66 59 62
ADVAIR DISKUS 68 62 61 44
BRIMONIDINE TARTRATE 67 67 62 138
TIMOLOL MALEATE 67 67 62 138
LEVOFLOXACIN 66 63 64 79
VANCOMYCIN HCL 65 41 65 141
SPIRIVA 65 64 65 47
ZETIA 64 64 67 143
GLIPIZIDE 64 64 67 34
NOVOLOG 62 57 69 80
LOSARTAN POTASSIUM 62 62 69 53
METHYLPHENIDATE HCL 60 53 71 148
BUPROPION HCL SR 59 49 72 150
ERYTHROMYCIN 58 55 73 95
METOCLOPRAMIDE HCL 58 19 73 105
HEPARIN SODIUM 58 20 73 155
METHOTREXATE 57 57 76 158
FLUTICASONE PROPIONATE 56 46 77 49
NYSTATIN 54 51 78 58
SANTYL 54 53 78 173
ALENDRONATE SODIUM 53 53 80 32
CLOPIDOGREL 50 49 81 71
SPS 50 16 81 188
FAMOTIDINE 50 46 81 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.